Ligation of Dectin-1 by fungal glucans elicits a Th17 response that is necessary for clearing many fungal pathogens. Laminarin is a (1→3, 1→6)-β-glucan that is widely reported to be a Dectin-1 antagonist, however, there are reports that laminarin is also a Dectin-1 agonist. To address this controversy, we assessed the physical properties, structure, purity, Dectin-1 binding, and biological activity of five different laminarin preparations from three different commercial sources. The proton nuclear magnetic resonance analysis indicated that all of the preparations contained laminarin although their molecular mass varied considerably (4400–34,400 Da). Two of the laminarins contained substantial quantities of very low m.w. compounds, some of which were not laminarin. These low m.w. moieties could be significantly reduced by extensive dialysis. All of the laminarin preparations were bound by recombinant human Dectin-1 and mouse Dectin-1, but the affinity varied considerably, and binding affinity did not correlate with Dectin-1 agonism, antagonism, or potency. In both human and mouse cells, two laminarins were Dectin-1 antagonists and two were Dectin-1 agonists. The remaining laminarin was a Dectin-1 antagonist, but when the low m.w. moieties were removed, it became an agonist. We were able to identify a laminarin that is a Dectin-1 agonist and a laminarin that is Dectin-1 antagonist, both of which are relatively pure preparations. These laminarins may be useful in elucidating the structure and activity relationships of glucan/Dectin-1 interactions. Our data demonstrate that laminarin can be either a Dectin-1 antagonist or agonist, depending on the physicochemical properties, purity, and structure of the laminarin preparation employed.
The fungal cell wall serves as the interface between the organism and its environment. Complex carbohydrates are a major component of the Candida albicans cell wall, i.e., glucan, mannan and chitin. β-Glucan is a pathogen associated molecular pattern (PAMP) composed of β-(1 → 3,1 → 6)-linked glucopyranosyl repeat units. This PAMP plays a key role in fungal structural integrity and immune recognition. Glycogen is an α-(1 → 4,1 → 6)-linked glucan that is an intracellular energy storage carbohydrate. We observed that glycogen was co-extracted during the isolation of β-glucan from C. albicans SC5314. We hypothesized that glucan and glycogen may form a macromolecular species that links intracellular glycogen with cell wall β-(1 → 3,1 → 6)-glucan. To test this hypothesis, we examined glucan-glycogen extracts by multi-dimensional NMR to ascertain if glycogen and β-glucan were interconnected. 1H NMR analyses confirmed the presence of glycogen and β-glucan in the macromolecule. Diffusion Ordered SpectroscopY (DOSY) confirmed that the β-glucan and glycogen co-diffuse, which indicates a linkage between the two polymers. We determined that the linkage is not via peptides and/or small proteins. Our data indicate that glycogen is covalently linked to β-(1 → 3,1 → 6) glucan via the β -(1 → 6)-linked side chain. We also found that the glucan-glycogen complex was present in C. dublinensis, C. haemulonii and C. auris, but was not present in C. glabrata or C. albicans hyphal glucan. These data demonstrate that glucan and glycogen form a novel macromolecular complex in the cell wall of C. albicans and other Candida species. This new and unique structure expands our understanding of the cell wall in Candida species.
Fungal mannans are located on the exterior of the fungal cell wall, where they interact with the environment and, ultimately, the human host. Mannans play a major role in shaping the innate immune response to fungal pathogens. Understanding the phosphodiester linkage and mannosyl repeat units in the acid-labile portion of mannans is crucial for comprehending their structure/activity relationships and for development of anti-fungal vaccines and immunomodulators. The phosphodiester linkages connect the acid-stable and acid-labile portions of the mannan polymer. Phosphate groups are attached to positions 4 and/or 6 of mannosyl repeat units in the acid-stable portion and to position 1 of mannosyl repeat units in the acid-labile portion. This review focuses on the synthesis of phosphodiester linkages as an approach to the development of mannan glycomimetics, which are based on natural product fungal mannans. Development of successful synthetic strategies for the phosphodiester linkages may enable the production of mannan glycomimetics that elicit anti-fungal immune responses against existing and emerging fungal pathogens, such as Candida albicans and Candida auris.
Clostridioides difficile polysaccharides (PSs) represent useful tools for the study of C. difficile pathogenesis. Water-soluble PS-I (pentaglycosyl-phosphate repeats) and PS-II (hexaglycosyl-phosphate repeats) and phenol-soluble lipoteichoic acid (LTA) PS-III have been previously identified. Most of the LTA PS-III repeats consist of two N -acetyl-glucopyranosamine (GlcNAc) units and glyceric acid (GroA), bridged by an exocyclic phosphodiester: →P-6)-α-D-GlcNAc-(1-3)-α-D-GlcNAc-[1-2-GroA]-(6→. Here, we describe a water-soluble PS from an equine C. difficile strain similar to PS-III, but with 6-substituted glucopyranosamine (GlcN) predominantly in the repeat: →P-6)-α-D-GlcN-(1-3)-α-D-GlcNAc-[1-2-GroA]-(6→ (coined wsPS-III). For analytical comparisons, the two saccharides, α-D-GlcN-(1-3)-α-D-GlcNAc-(1-2)-GroA and α-D-GlcNAc-(1-3)-α-D-GlcNAc-(1-2)-GroA, were chemically synthesized, and the transformation product, Gro-(1-P-6)-α-D-GlcNAc-(1-2)-GroA, was generated by Smith degradation. Pre-existing circulating IgG antibodies in horse sera due to natural exposure reacted with wsPS-III, and inoculation of rabbits with wsPS-III afforded IgG antibodies that reacted with C. difficile . It is postulated that the zwitterionic nature of wsPS-III is the driving force behind the observed solubility and immunogenicity. The glycans presented here will be useful in investigations concerning C. difficile biosynthetic pathways, virulence, antibiotics and vaccines.
Campylobacter jejuni tops the list of bacteria responsible for gastroenteritis in humans. Knowledge of capsular polysaccharide (CPS) fine structure allows for the design of chemical conjugation strategies and identification of gene clusters for bioconjugations. CPSs are the basis for a multivalent C. jejuni glycoconjugate vaccine that has as key serological markers variably linked O-methyl-phosphoramidate (MeOPN) moieties and heptoses of rare configurations. Previously, the activation strategy for C. jejuni CPSs whose backbones contained no vicinal diols (serotypes HS:4, HS:10, HS:15, HS:23/36 and HS:53) was based on oxidation of the non-reducing end sugar with periodate, followed by conjugation to protein via reductive amination. Here, we describe the approach taken to functionalize C. jejuni CPSs with inner regions susceptible to periodate centered on TEMPO/bleach-mediated oxidation of primary hydroxyls to carboxyls followed by carbodiimide-directed conjugation. This work describes the syntheses and immunogenicities of such C. jejuni CPS-conjugates, specifically those of serotypes HS:1, HS:2 and HS:3. The stoichiometric TEMPO/bleach-oxidation of CPSs showed preference for specific primary hydroxyl groups, such as C7 of 6-deoxy-heptoses, and furnished conjugates that induced strong IgG responses against the native C. jejuni CPSs. It is postulated that the enhanced immunogenicity of the described conjugates is due to the preservation of CPS structures and the zwitterionic character of CPSs, afforded by the native MeOPN units and unreacted carboxyls.